Skip to main content
SpringerLink
Log in

Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis

  • Correspondence
  • Published:
Journal of Perinatology Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Arima M, Akiyama M, Fujiwara K, Mori Y, Inoue H, Seki E, et al. Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity. PLoS ONE. 2020;15:e0230678.

    Article  CAS  Google Scholar 

  2. Blair MP, Shapiro MJ, Ad Hoc Group Concerning Neurodevelopment and antiVEGF. Re: Good: Bevacizumab for retinopathy of prematurity: treatment when pathology is embedded in a normally developing vascular system (Ophthalmology. 2016;123:1843-1844). Ophthalmology. 2017;124:e74–e75.

    Article  Google Scholar 

  3. Rodriguez SH, Blair MP, Shapiro MJ, Berrocal AM, Murray TG, Martinez-Castellanos MA, et al. Neurodevelopmental outcomes of preterm infants with retinopathy of prematurity by treatment. Pediatrics. 2020;145:e20200056A.

    Article  Google Scholar 

  4. Raghuram K, Isaac M, Yang J, AlAli A, Mireskandari K, Ly LG, et al. Neurodevelopmental outcomes in infants treated with intravitreal bevacizumab versus laser. J Perinatol. 2019;39:1300–8.

    Article  CAS  Google Scholar 

  5. Fan YY, Huang YS, Huang CY, Hsu JF, Shih CP, Hwang YS, et al. Neurodevelopmental outcomes after intravitreal bevacizumab therapy for retinopathy of prematurity: a prospective case-control study. Ophthalmology. 2019;126:1567–77.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The University of Chicago, Chicago, IL, USA

    Sarah Hilkert Rodriguez

  2. Retina Consultants, Ltd., The University of Chicago, Chicago, IL, USA

    Michael P. Blair

  3. Retina Consultants, Ltd., The University of Illinois, Chicago, IL, USA

    Michael J. Shapiro

  4. Bascom Palmer Eye Institute, Miami, FL, USA

    Audina M. Berrocal

  5. Calgary Retina Consultants, The University of Calgary, Calgary, AB, Canada

    Anna L. Ells

  6. Emory Eye Center, Atlanta, GA, USA

    G. Baker Hubbard III

  7. Asociacion Para Evitar la Ceguera en Mexico, I.A.P. Hospital “Dr. Luis Sanchez Bulnes”, Cabo San Lucas, Mexico

    Maria Ann Martinez-Castellanos

  8. Murray Ocular Oncology and Retina, Miami, FL, USA

    Timothy G. Murray

  9. Chang Gung Memorial Hospital, Taoyuan, Taiwan

    Wei-Chi Wu

Authors
  1. Sarah Hilkert Rodriguez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael P. Blair
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael J. Shapiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Audina M. Berrocal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anna L. Ells
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Baker Hubbard III
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Maria Ann Martinez-Castellanos
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Timothy G. Murray
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Wei-Chi Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah Hilkert Rodriguez.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rodriguez, S.H., Blair, M.P., Shapiro, M.J. et al. Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis. J Perinatol 41, 2377–2378 (2021). https://doi.org/10.1038/s41372-021-01133-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-021-01133-3

  • Springer Nature America, Inc.

Search

Navigation